| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74513 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74210 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70857 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64946-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-72107 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-22542-50ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-41296-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-49891-0.1mg | |||
| BSA Free | NBP2-49891-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-71793 | |||
![Western Blot: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TIA1.](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Western-Blot-NBP2-46132-img0008.jpg "Western Blot: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TIA1.")
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Adenocarcinoma of Human colon tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0007.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Human prostate tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0001.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Human breast tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0002.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Human colon tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0003.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Carcinoma of Human liver tissue.(Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0004.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0005.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0006.jpg)
![TIA1 Antibody (OTI1D7)[NBP2-46132]Simple Western� analysis of endogenous protein TLE1 from A549 lysates (0.2 mg/mL) using TLE1 Mouse Monoclonal Antibody . The virtual lane view (left) shows the target (as indicated) at 1:50 dilution of primary antibody. The corresponding electropherogram view (right) plots chemiluminescence by molecular weight along the capillary at a 1:50 dilution of primary antibody. This experiment was performed under reducing conditions on the Jess� Simple Western instrument from ProteinSimple, a Bio-Techne brand, using the 12�230 kDa Separation Module.](http://images.novusbio.com/fullsize/nbp2-46132_mouse-tia1-mab-oti1d7-simple-western-1311202512362223.jpg%253fstore=america&image-type=image)
![Western Blot: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Western-Blot-NBP2-45867-img0016.jpg "Western Blot: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2.")
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Human lung tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0015.jpg)
![Flow Cytometry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of HEK293T cells transfected with either overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by SLA2 antibody.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Flow-Cytometry-NBP2-45867-img0001.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Carcinoma of Human thyroid tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0002.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Carcinoma of Human kidney tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0003.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Human breast tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0004.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Adenocarcinoma of Human breast tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0005.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Adenocarcinoma of Human endometrium tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0006.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Carcinoma of Human prostate tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0007.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Adenocarcinoma of Human colon tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0008.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Human pancreas tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0009.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0010.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Human colon tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0011.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Human prostate tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0012.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Human bladder tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0013.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0014.jpg)
![Western Blot: Glutathione S-Transferase pi 1/GSTP1 Antibody (4B6) [NBP2-45916] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY GSTP1.](http://images.novusbio.com/fullsize/Glutathione-S-Transferase-pi-1-GSTP1-Antibody-4B6-Western-Blot-NBP2-45916-img0010.jpg "Western Blot: Glutathione S-Transferase pi 1/GSTP1 Antibody (4B6) [NBP2-45916] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY GSTP1.")
![Immunohistochemistry: Glutathione S-Transferase pi 1/GSTP1 Antibody (4B6) [NBP2-45916] - Analysis of Carcinoma of Human thyroid tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/Glutathione-S-Transferase-pi-1-GSTP1-Antibody-4B6-Immunohistochemistry-NBP2-45916-img0009.jpg)
![Immunohistochemistry: Glutathione S-Transferase pi 1/GSTP1 Antibody (4B6) [NBP2-45916] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/Glutathione-S-Transferase-pi-1-GSTP1-Antibody-4B6-Immunohistochemistry-NBP2-45916-img0001.jpg)
![Immunohistochemistry: Glutathione S-Transferase pi 1/GSTP1 Antibody (4B6) [NBP2-45916] - Analysis of Adenocarcinoma of Human colon tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/Glutathione-S-Transferase-pi-1-GSTP1-Antibody-4B6-Immunohistochemistry-NBP2-45916-img0002.jpg)
![Immunohistochemistry: Glutathione S-Transferase pi 1/GSTP1 Antibody (4B6) [NBP2-45916] - Analysis of Human prostate tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/Glutathione-S-Transferase-pi-1-GSTP1-Antibody-4B6-Immunohistochemistry-NBP2-45916-img0003.jpg)
![Immunohistochemistry: Glutathione S-Transferase pi 1/GSTP1 Antibody (4B6) [NBP2-45916] - Analysis of Human pancreas tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/Glutathione-S-Transferase-pi-1-GSTP1-Antibody-4B6-Immunohistochemistry-NBP2-45916-img0004.jpg)
![Immunohistochemistry: Glutathione S-Transferase pi 1/GSTP1 Antibody (4B6) [NBP2-45916] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/Glutathione-S-Transferase-pi-1-GSTP1-Antibody-4B6-Immunohistochemistry-NBP2-45916-img0005.jpg)
![Immunohistochemistry: Glutathione S-Transferase pi 1/GSTP1 Antibody (4B6) [NBP2-45916] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/Glutathione-S-Transferase-pi-1-GSTP1-Antibody-4B6-Immunohistochemistry-NBP2-45916-img0006.jpg)
![Immunohistochemistry: Glutathione S-Transferase pi 1/GSTP1 Antibody (4B6) [NBP2-45916] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/Glutathione-S-Transferase-pi-1-GSTP1-Antibody-4B6-Immunohistochemistry-NBP2-45916-img0007.jpg)
![Immunohistochemistry: Glutathione S-Transferase pi 1/GSTP1 Antibody (4B6) [NBP2-45916] - Analysis of Human thyroid tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/Glutathione-S-Transferase-pi-1-GSTP1-Antibody-4B6-Immunohistochemistry-NBP2-45916-img0008.jpg)
![Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Cabanel M, Brand C, Oliveira-Nunes MC, Cabral-Piccin MP, Lopes MF, Brito JM, et al. (2015) Epigenetic Control of Macrophage Shape Transition towards an Atypical Elongated Phenotype by Histone Deacetylase Activity. PLoS ONE 10(7): e0132984.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunocytochemistry-Immunofluorescence-NB100-64946-img0022.jpg "Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Cabanel M, Brand C, Oliveira-Nunes MC, Cabral-Piccin MP, Lopes MF, Brito JM, et al. (2015) Epigenetic Control of Macrophage Shape Transition towards an Atypical Elongated Phenotype by Histone Deacetylase Activity. PLoS ONE 10(7): e0132984.")
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Benard A, Sala C, Pluschke G (2016)Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates.PLoS ONE 11(11): e0167059](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0026.jpg)
![Flow Cytometry: Macrophage Antibody (MOMA-2) [NB100-64946] - Staining of mouse peritoneal macrophages with RPE conjugated Rat anti Mouse Macrophages/Monocytes following permeabilisation with Leucoperm](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Flow-Cytometry-NB100-64946-img0007.jpg)
![Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Nix RN, Altschuler SE, Henson PM, Detweiler CS (2007) Hemophagocytic Macrophages Harbor Salmonella enterica during Persistent Infection.PLoS Pathog 3(12): e193.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunocytochemistry-Immunofluorescence-NB100-64946-img0010.jpg)
![Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Nix RN, Altschuler SE, Henson PM, Detweiler CS (2007) Hemophagocytic Macrophages Harbor Salmonella enterica during Persistent Infection.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunocytochemistry-Immunofluorescence-NB100-64946-img0011.jpg)
![Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Nix RN, Altschuler SE, Henson PM, Detweiler CS (2007) Hemophagocytic Macrophages Harbor Salmonella enterica during Persistent Infection.PLoS Pathog 3(12): e193.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunocytochemistry-Immunofluorescence-NB100-64946-img0012.jpg)
![Immunocytochemistry/Immunofluorescence: Macrophage Antibody (MOMA-2) [NB100-64946] - Dong M, Zhong L, Chen WQ, Ji XP, Zhang M, Zhao YX, et al. (2012) Doxycycline Stabilizes Vulnerable Plaque via Inhibiting Matrix Metalloproteinases and Attenuating Inflammation in Rabbits.PLoS ONE 7(6): e39695.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunocytochemistry-Immunofluorescence-NB100-64946-img0014.jpg)
![<b>Genetic Strategies Validation. </b>Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Marie-Claude Bourdillon, Jacques Randon, Lydie Barek, et al.,](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0006.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Ruschke K, Ebelt H, Kloting N, Boettger T, Raum K, Bluher M, et al. (2009) Defective Peripheral Nerve Development Is Linked to Abnormal Architecture and Metabolic Activity of Adipose Tissue in Nscl-2 Mutant Mice.PLoS ONE 4(5): e5516.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0009.jpg)
![<b>Genetic Strategies Validation. </b>Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Seno T, Hamaguchi M, Ashihara E, Kohno M, Ishino H, Yamamoto A, et al. (2011) 15-Deoxy-delta 12,14 Prostaglandin J2 Reduces the Formation of Atherosclerotic Lesions in Apolipoprotein E Knockout Mice. PLoS ONE 6(10): e25541.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0013.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Chyu K-Y, Zhao X, Dimayuga PC, Zhou J, Li X, Yano J, et al. (2012) CD8+ T Cells Mediate the Athero-Protective Effect of Immunization with an ApoB-100 Peptide.PLoS ONE 7(2): e30780.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0015.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Wang B, Dai S, Dong Z, Sun Y, Song X, Guo C, et al. (2014) The Modulation of Endoplasmic Reticulum Stress by Chemical Chaperone Upregulates Immune Negative Cytokine IL-35 in Apolipoprotein E-Deficient Mice.PLoS ONE 9(1): e87787.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0016.jpg)
![<b>Genetic Strategies Validation. </b>Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Liu XL, Zhang PF, Ding SF, Wang Y, Zhang M, Zhao YX, et al. (2012) Local Gene Silencing of Monocyte Chemoattractant Protein-1 Prevents Vulnerable Plaque Disruption in Apolipoprotein E-Knockout Mice.PLoS ONE 7(3): e33497.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0017.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Chyu K-Y, Lio WM, Dimayuga PC, Zhou J, Zhao X, Yano J, et al. (2014) Cholesterol Lowering Modulates T Cell Function In Vivo and In Vitro. PLoS ONE 9(3): e92095.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0018.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Kennedy A, Gruen ML, Gutierrez DA, Surmi BK, Orr JS, Webb CD, et al. (2012) Impact of Macrophage Inflammatory Protein-1a Deficiency on Atherosclerotic Lesion Formation, Hepatic Steatosis, and Adipose Tissue Expansion.PLoS ONE 7(2): e31508.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0020.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Wang L, Yang M, Arias A, Song L, Li F, Tian F, et al. (2015) Splenocytes Seed Bone Marrow of Myeloablated Mice: Implication for Atherosclerosis. PLoS ONE 10(6): e0125961.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0021.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Niven J, Hoare J, McGowan D, Devarajan G, Itohara S, Gannage M, et al. (2015) S100B Up-Regulates Macrophage Production of IL1b and CCL22 and Influences Severity of Retinal Inflammation.PLoS ONE 10(7): e0132688.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0024.jpg)
![Immunohistochemistry: Macrophage Antibody (MOMA-2) [NB100-64946] - Shuto Y, Asai A, Nagao M, Sugihara H, Oikawa S (2015) Repetitive Glucose Spikes Accelerate Atherosclerotic Lesion Formation in C57BL/6 Mice.PLoS ONE 10(8): e0136840.](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Immunohistochemistry-NB100-64946-img0025.jpg)
![Flow Cytometry: Macrophage Antibody (MOMA-2) [NB100-64946] - Staining of mouse peritoneal macrophages with FITC conjugated Rat anti Mouse Macrophages/Monocytes following permeabilisation with Leucoperm](http://images.novusbio.com/fullsize/Macrophage-Antibody-MOMA-2-Flow-Cytometry-NB100-64946-img0001.jpg)
![Western Blot: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLAMF7.](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Western-Blot-NBP2-45868-img0005.jpg "Western Blot: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLAMF7.")
![Immunohistochemistry-Paraffin: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Paraffin-embedded Carcinoma of Human prostate tissue using anti-SLAMF7 mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min.](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Immunohistochemistry-Paraffin-NBP2-45868-img0006.jpg)
![Immunohistochemistry: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of Adenocarcinoma of Human breast tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Immunohistochemistry-NBP2-45868-img0001.jpg)
![Immunohistochemistry: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Immunohistochemistry-NBP2-45868-img0002.jpg)
![Immunohistochemistry: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Immunohistochemistry-NBP2-45868-img0003.jpg)
![Immunohistochemistry: CRACC/SLAMF7 Antibody (OTI1F1) [NBP2-45868] - Analysis of Adenocarcinoma of Human endometrium tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CRACC-SLAMF7-Antibody-OTI1F1-Immunohistochemistry-NBP2-45868-img0004.jpg)
![Western Blot: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of 25 ug of Raji (Lane 1), Jurkat (Lane 2), and BAF-3 cell lysates (Lane 3) and a molecular weight protein ladder.](http://images.novusbio.com/fullsize/CD58-LFA-3-Antibody-TS2-9-Western-Blot-NBP2-22542-img0005.jpg "Western Blot: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of 25 ug of Raji (Lane 1), Jurkat (Lane 2), and BAF-3 cell lysates (Lane 3) and a molecular weight protein ladder.")
![Immunocytochemistry/Immunofluorescence: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of CD58 (green) showing staining in the cytoplasm of Raji cells (right) compared to a negative control without primary antibody (left).](http://images.novusbio.com/fullsize/CD58-LFA-3-Antibody-TS2-9-Immunocytochemistry-Immunofluorescence-NBP2-22542-img0004.jpg)
![Flow Cytometry: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of CD58 in BAF-3 cells compared to an isotype control (blue).](http://images.novusbio.com/fullsize/CD58-LFA-3-Antibody-TS2-9-Flow-Cytometry-NBP2-22542-img0003.jpg)
![Flow Cytometry: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of CD58 in PBMC cells compared to an isotype control (blue).](http://images.novusbio.com/fullsize/CD58-LFA-3-Antibody-TS2-9-Flow-Cytometry-NBP2-22542-img0001.jpg)
![Flow Cytometry: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of CD58 in PBMC cells compared to an isotype control (blue).](http://images.novusbio.com/fullsize/CD58-LFA-3-Antibody-TS2-9-Flow-Cytometry-NBP2-22542-img0002.jpg)
![Western Blot: BATF3 Antibody [NBP2-41296] - Analysis of BATF3 in 293 cell lysate with BATF3 antibody at 0.5 ug/ml in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/BATF3-Antibody-Western-Blot-NBP2-41296-img0002.jpg "Western Blot: BATF3 Antibody [NBP2-41296] - Analysis of BATF3 in 293 cell lysate with BATF3 antibody at 0.5 ug/ml in (A) the absence and (B) the presence of blocking peptide.")
![Immunohistochemistry: BATF3 Antibody [NBP2-41296] - Immunohistochemistry of BATF3 in human kidney tissue with BATF3 antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/BATF3-Antibody-Immunohistochemistry-NBP2-41296-img0003.jpg)
![Immunofluorescence: BATF3 Antibody [NBP2-41296] - Immunofluorescence of BATF3 in human kidney tissue with BATF3 Antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/BATF3-Antibody-Immunofluorescence-NBP2-41296-img0004.jpg)
![Immunocytochemistry/ Immunofluorescence: BATF3 Antibody - BSA Free [NBP2-41296] - Immunofluorescence of BATF3 in human kidney tissue with BATF3 Antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp2-41296_rabbit-polyclonal-batf3-antibody-2711202419313277.gif)
![Immunohistochemistry: BATF3 Antibody - BSA Free [NBP2-41296] - Immunohistochemistry of BATF3 in human kidney tissue with BATF3 antibody at 5 u/mL.](http://images.novusbio.com/fullsize/nbp2-41296_rabbit-polyclonal-batf3-antibody-2711202420285889.gif)
![Immunohistochemistry: BATF3 Antibody - BSA Free [NBP2-41296] - Immunohistochemistry of BATF3 in human kidney tissue with BATF3 antibody at 5 u/mL.](http://images.novusbio.com/fullsize/nbp2-41296_rabbit-polyclonal-batf3-antibody-2711202419201566.gif)
![Immunocytochemistry/ Immunofluorescence: BATF3 Antibody - BSA Free [NBP2-41296] - Immunofluorescence of BATF3 in human kidney tissue with BATF3 Antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp2-41296_rabbit-polyclonal-batf3-antibody-2711202419172279.gif)
![Immunocytochemistry/Immunofluorescence: Complement Component C1qA Antibody (3R9/2) [NB100-64729] - C4d deposition in graft biopsies of patients with DGF. C4d (green, E) co-localized with C1QA (red, G) at peri-tubular capillary sites (merge, I). TO-PRO-3 (blue) was used to stain nuclei. Original magnifications were (E-J) x630.](http://images.novusbio.com/fullsize/Complement-Component-C1qA-Antibody-3R9-2-Immunocytochemistry-Immunofluorescence-NB100-64729-img0006.jpg "Immunocytochemistry/Immunofluorescence: Complement Component C1qA Antibody (3R9/2) [NB100-64729] - C4d deposition in graft biopsies of patients with DGF. C4d (green, E) co-localized with C1QA (red, G) at peri-tubular capillary sites (merge, I). TO-PRO-3 (blue) was used to stain nuclei. Original magnifications were (E-J) x630.")
![Flow Cytometry: Complement Component C1qA Antibody (3R9/2) [NB100-64729]](http://images.novusbio.com/fullsize/Complement-Component-C1qA-Antibody-3R9-2-Flow-Cytometry-NB100-64729-img0007.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a DyLight 649 and Mouse IgG1 FITC isotype control. Figure B. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a PE and Mouse anti Canine CD3 FITC.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0009.jpg "Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a DyLight 649 and Mouse IgG1 FITC isotype control. Figure B. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a PE and Mouse anti Canine CD3 FITC.")
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A: APC conjugated rat anti-Canine CD4 and FITC conjugated mouse IgG1 isotype control. Figure B: APC conjugated rat anti-Canine CD4 and FITC conjugated mouse anti-Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0001.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A: RPE conjugated Rat anti-Dog CD4 and Mouse IgG1 isotype control labeled with Goat anti-Mouse FITC. Figure B: RPE conjugated Rat anti-Dog CD4 and Mouse anti-Dog CD3 labeled with Goat anti Mouse DyLight FITC.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0002.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. Alexa Fluor 700 conjugated Rat anti Canine CD8 and FITC conjugated Mouse IgG1 isotype control. Figure B. Alexa Fluor 700 conjugated Rat anti Canine CD8 and FITC conjugated Mouse anti Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0003.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat IgG2a isotype control. Figure B. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat anti Canine CD4.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0004.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. RPE conjugated Rat anti Canine CD4 and FITC conjugated Mouse IgG1 isotype control. Figure B. RPE conjugated Rat anti Canine CD4 and FITC conjugated Mouse anti Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0005.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. RPE conjugated Rat anti Canine CD8 and FITC conjugated Mouse IgG1 isotype control. Figure B. RPE conjugated Rat anti Canine CD8 and FITC conjugated Mouse anti Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0006.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat IgG1 isotype control. Figure B. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat anti Canine CD8.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0007.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. FITC conjugated Mouse anti Canine CD3 and purified Rat IgG2a isotype control detected with Goat anti Rat IgG2a DyLight 649. Figure B. FITC conjugated Mouse anti Canine CD3 and purified Mouse anti Canine CD90 detected with Goat anti Rat IgG2a DyLight 649.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0008.jpg)
![Western Blot: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CLEC4E.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Western-Blot-NBP2-45629-img0009.jpg "Western Blot: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CLEC4E.")
![Immunohistochemistry: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of Human Ovary tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Immunohistochemistry-NBP2-45629-img0008.jpg)
![Flow Cytometry: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of HEK293T cells transfected with either RC200244 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by CLEC4E antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Flow-Cytometry-NBP2-45629-img0001.jpg)
![Immunohistochemistry: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of Human pancreas tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Immunohistochemistry-NBP2-45629-img0002.jpg)
![Immunohistochemistry: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Immunohistochemistry-NBP2-45629-img0003.jpg)
![Immunohistochemistry: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of Human lymphoma tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Immunohistochemistry-NBP2-45629-img0004.jpg)
![Immunohistochemistry: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of Carcinoma of Human prostate tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Immunohistochemistry-NBP2-45629-img0005.jpg)
![Immunohistochemistry: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Immunohistochemistry-NBP2-45629-img0006.jpg)
![Immunohistochemistry: CLEC4E Antibody (2A8) [NBP2-45629] - Analysis of Adenocarcinoma of Human endometrium tissue.](http://images.novusbio.com/fullsize/CLEC4E-Antibody-2A8-Immunohistochemistry-NBP2-45629-img0007.jpg)
![Immunohistochemistry: Hyaluronidase 1/HYAL1 Antibody [NBP1-00201] - (5ug/ml) staining of paraffin embedded Human Liver. Steamed antigen retrieval with citrate buffer pH 6, AP-staining.](http://images.novusbio.com/fullsize/Hyaluronidase-1-HYAL1-Antibody-Immunohistochemistry-NBP1-00201-img0004.jpg "Immunohistochemistry: Hyaluronidase 1/HYAL1 Antibody [NBP1-00201] - (5ug/ml) staining of paraffin embedded Human Liver. Steamed antigen retrieval with citrate buffer pH 6, AP-staining.")
![Flow Cytometry: Hyaluronidase 1/HYAL1 Antibody [NBP1-00201] - Analysis of paraformaldehyde fixed HepG2 cells (blue line), permeabilized with 0.5% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (1ug/ml). IgG control: Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/Hyaluronidase-1-HYAL1-Antibody-Flow-Cytometry-NBP1-00201-img0003.jpg)
![Immunofluorescence: Hyaluronidase 1/HYAL1 Antibody [NBP1-00201] - Analysis of paraformaldehyde fixed A431 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).](http://images.novusbio.com/fullsize/Hyaluronidase-1-HYAL1-Antibody-Immunofluorescence-NBP1-00201-img0001.jpg)
![Immunofluorescence: Hyaluronidase 1/HYAL1 Antibody [NBP1-00201] - Analysis of paraformaldehyde fixed HeLa cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).](http://images.novusbio.com/fullsize/Hyaluronidase-1-HYAL1-Antibody-Immunofluorescence-NBP1-00201-img0002.jpg)
![Western Blot: CD14 Antibody [NB100-2807] - Staining (1ug/ml) of PBM lysate (35ug protein in RIPA buffer) with (B) and without (A) blocking with the immunizing peptide. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/CD14-Antibody-Flow-Cytometry-NB100-2807-img0006.jpg "Western Blot: CD14 Antibody [NB100-2807] - Staining (1ug/ml) of PBM lysate (35ug protein in RIPA buffer) with (B) and without (A) blocking with the immunizing peptide. Detected by chemiluminescence.")
![Flow Cytometry: CD14 Antibody [NB100-2807] - Flow cytometric analysis of paraformaldehyde fixed A549 cells (blue line), permeabilized with 0.5% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (1ug/ml). IgG control: Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/CD14-Antibody-Flow-Cytometry-NB100-2807-img0005.jpg)
![Immunohistochemistry: Goat Polyclonal CD14 Antibody [NB100-2807] - (8µg/ml) staining of paraffin embedded Human Tonsil. Heat induced antigen retrieval with citrate buffer pH 6, HRP-staining.](http://images.novusbio.com/fullsize/antibody/nb100-2807_goat-polyclonal-cd14-antibody-imgenex-img-3991-immunohistochemistry-283202413831..jpg)
![Control: Goat Polyclonal CD14 Antibody [NB100-2807] - Negative Control showing staining of paraffin embedded Human Tonsil, with no primary antibody.](http://images.novusbio.com/fullsize/antibody/nb100-2807_goat-polyclonal-cd14-antibody-imgenex-img-3991-control-283202413949..jpg)